Skip to main content

Table 1 Patients’ characteristics and clinical results

From: Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer

  Age (years) T-stage Gleason-score PSA pre-RT(ng/ml) NCCN-risk-category Max. GI-toxicity Max. GU-toxicity
Pat 1 67 1c 3+3 7.6 low 1 1
Pat 2 67 1c 3+4 9.9 intermediate 1 1
Pat 3 76 2b 3+4 4.4 intermediate 1 1
Pat 4 60 1c 3+4 5.8 intermediate 1 2
Pat 5 67 1c 3+4 5.1 intermediate 1 1
Pat 6 79 2a 4+3 9.9 intermediate 1 2
Pat 7 78 1c 3+4 13 intermediate 0 2
Pat 8 76 1c 4+3 9.2 intermediate 0 2
Pat 9 75 1c 4+3 3.9 intermediate 0 1
Pat 10 66 1c 3+3 8.5 low 1 2
  1. Abbreviations
  2. GI – gastrointestinal (RTOG).
  3. GU – genitourinary (RTOG).
  4. NCCN – national comprehensive cancer network.
  5. Pat – Patient.
  6. RT – radiotherapy.